Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies
View ORCID ProfileOmar Hasan Ali, David Bomze, Lorenz Risch, Silvio D. Brugger, Matthias Paprotny, Myriam Weber, Sarah Thiel, Lukas Kern, Werner C. Albrich, Philipp Kohler, Christian R. Kahlert, Pietro Vernazza, Philipp K. Bühler, Reto A. Schüpbach, Alejandro Gómez-Mejia, Alexandra M. Popa, Andreas Bergthaler, Josef M. Penninger, Lukas Flatz
doi: https://doi.org/10.1101/2020.07.21.20159244
Omar Hasan Ali
1Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada
2Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
3Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
MDDavid Bomze
3Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
4Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
MScLorenz Risch
5Labormedizinisches Zentrum Dr. Risch, Vaduz, Liechtenstein
6Center of Laboratory Medicine, University Institute of Clinical Chemistry, University of Bern, Bern, Switzerland
MD, PhD, MPHSilvio D. Brugger
7Department of Infectious Diseases and Hospital Hygiene, University Hospital Zurich, Zurich, Switzerland
MD, PhDMatthias Paprotny
8Department of General Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein
MDMyriam Weber
8Department of General Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein
MDSarah Thiel
8Department of General Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein
MDLukas Kern
9Department of Pulmonology, Kantonsspital St. Gallen, St. Gallen, Switzerland
MDWerner C. Albrich
10Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St.Gallen, St. Gallen, Switzerland
MD, MSCRPhilipp Kohler
10Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St.Gallen, St. Gallen, Switzerland
MDChristian R. Kahlert
10Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St.Gallen, St. Gallen, Switzerland
11Department of Infectious Diseases and Hospital Epidemiology, Children’s Hospital of Eastern Switzerland, St. Gallen, Switzerland
MDPietro Vernazza
10Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St.Gallen, St. Gallen, Switzerland
MDPhilipp K. Bühler
12Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland
MDReto A. Schüpbach
12Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland
MDAlejandro Gómez-Mejia
7Department of Infectious Diseases and Hospital Hygiene, University Hospital Zurich, Zurich, Switzerland
PhDAlexandra M. Popa
13Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
PhDAndreas Bergthaler
13Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
DVMJosef M. Penninger
1Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada
14IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
MDLukas Flatz
2Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
3Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland
15Department of Dermatology, Kantonsspital St. Gallen, St. Gallen, Switzerland
16Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland
MDData Availability
The authors confirm that the data supporting the findings of this study are available within the article.
Posted July 24, 2020.
Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies
Omar Hasan Ali, David Bomze, Lorenz Risch, Silvio D. Brugger, Matthias Paprotny, Myriam Weber, Sarah Thiel, Lukas Kern, Werner C. Albrich, Philipp Kohler, Christian R. Kahlert, Pietro Vernazza, Philipp K. Bühler, Reto A. Schüpbach, Alejandro Gómez-Mejia, Alexandra M. Popa, Andreas Bergthaler, Josef M. Penninger, Lukas Flatz
medRxiv 2020.07.21.20159244; doi: https://doi.org/10.1101/2020.07.21.20159244
Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies
Omar Hasan Ali, David Bomze, Lorenz Risch, Silvio D. Brugger, Matthias Paprotny, Myriam Weber, Sarah Thiel, Lukas Kern, Werner C. Albrich, Philipp Kohler, Christian R. Kahlert, Pietro Vernazza, Philipp K. Bühler, Reto A. Schüpbach, Alejandro Gómez-Mejia, Alexandra M. Popa, Andreas Bergthaler, Josef M. Penninger, Lukas Flatz
medRxiv 2020.07.21.20159244; doi: https://doi.org/10.1101/2020.07.21.20159244
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)